CHARLESTON, S.C. -- (BUSINESS WIRE) -- SCRA today announced its first tenant to lease space at the SCRA Applied Technologies Center at Nexton in Summerville, S.C., which is currently under construction. Aeterna Zentaris will occupy the third floor of the building and is scheduled to move in upon completion of the new facility this fall.
Aeterna Zentaris (NASDAQ: AEZS, TSX: AEZ) is a Canadian specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. With operations in Quebec City Canada and Frankfurt, Germany, the company recently established its North American business and global commercial operations in Charleston, South Carolina, in early June. Approximately 60 direct jobs are expected in the state over the next few years.
Company Chairman and CEO, David Dodd, is a S.C. Low country resident and has successfully led multiple biopharmaceutical ventures throughout his career. These include: Wyeth, Solvay Pharmaceuticals, Serologicals Corporation, BioReliance Corporation and other operations where he has either served as an executive or board member.
“We are delighted to locate operations at the beautifully designed and easily accessible SCRA Applied Technologies Center,” said Dodd. “We look forward to working with SCRA and contributing to the local economy.”
SCRA broke ground at the Nexton campus in October of 2013 and expects to complete construction in September of 2014. The Applied Technologies Center will house SCRA Charleston-area operations and the majority of the company's Charleston-area employees. Tenant companies will lease space as it is available.
“SCRA is pleased to welcome Aeterna Zentaris to South Carolina,” said SCRA CEO Bill Mahoney. “This outstanding company is developing life changing technologies and will be a significant cog in South Carolina’s Knowledge Economy.”
SCRA is an applied research corporation with over 30 years of experience delivering technology solutions with high returns on investment to federal and corporate clients. To fulfill our mission, SCRA has three sectors: Our Technology Ventures sector has helped over 290 early-stage companies to commercialize innovations and create jobs, our Applied R&D sector manages over 100 national and international programs worth over $2 billion in contract value, and our R&D Facilities sector builds and manages research facilities that include wet labs, secure rooms for sensitive work and advanced, high-tech manufacturing shops. Multiple economic impact studies show SCRA’s cumulative output into South Carolina’s economy to be over $16.6 billion.